Evidence suggests that dietary interventions can effectively delay, treat and even prevent certain illnesses. This leads to the hypothesis that metabolic interventions might aid cancer treatment, and this is the focus of the conversation with one of the most distinguished researchers in the field.
The guest of this episode of TJ Talks, hosted by prof. Giancarlo Pruneri, is dr. Claudio Vernieri, breast oncologist at the National Cancer Institute of Milan, and PI of the Breakfast-2 study. Breakfast-2 is a very promising prospective study on the efficacy of a metabolic intervention combined to chemo-immunotherapy for patients with triple negative breast cancer.